$SEM

Weigl Christopher sold (to issuer) $204K of SEM

Weigl Christopher (SENIOR VICE PRESIDENT) sold (to issuer) 12,382 shares of SELECT MEDICAL HOLDINGS CORP (SEM) at $16.50 ($0.20M total) on 2026-06-30.

Original reporting
SEC EDGAR · Weigl Christopher
Published Jul 1, 2026, 6:19 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 1, 2026, 6:27 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$SEM
Neutral
medium confidence
Mentioned
$SEM
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SEMNeutralLow
01

Why it matters

The disclosure provides a concrete datapoint on insider selling activity (shares, price, and post-transaction holdings) but does not include new operational, financial, or regulatory information.

02

Market read

Traders may monitor for sentiment effects, but the filing alone is unlikely to change valuation absent additional company-specific catalysts.

03

What to watch

No 10b5-1 plan is indicated, but the filing still doesn’t provide motive; traders should avoid over-weighting insider-sale narratives without corroborating fundamental news.

Relevance 4/10Novelty 5/10Timing: Filed 2026-07-01 after-hours/late day; reflects 2026-06-30 transaction.

Background

The article is an SEC Form 4 insider transaction disclosure for Select Medical Holdings Corp.

Company-level read

Ticker impact

$SEMNeutralMedium confidence
Context

Select Medical Holdings insider Weigl Christopher sold 12,382 shares to the issuer at $16.50 on 2026-06-30, per Form 4.

Expected impact

Low likelihood of a sustained price move; any impact is likely short-lived and sentiment-driven.

Evidence & confidence

Form 4 shows a specific sale size and price, but insider sales—especially to the issuer—are often mechanical and not necessarily tied to new fundamentals.

Market effects

Minimal; this is company-specific insider activity with no sector-wide catalyst.

None indicated.

None indicated.

Counterpoint

Because the sale is coded as “sale to issuer,” it may be part of a structured program (e.g., buyback participation), reducing the bearish interpretation.

Key entities

  • Select Medical Holdings Corp

    Subject of the Form 4 insider transaction disclosure.

  • Weigl Christopher

    Senior Vice President who sold shares to the issuer.

Related articles

$QXOHighAI 9/10

Are KORE, SEM, BLD, QXO Obtaining Fair Deals for their Shareholders?

Halper Sadeh LLC said it is investigating potential securities-law or fiduciary-duty issues in deals involving KORE Group Holdings’ sale to Searchlight Capital Partners and Abry Partners for $9.25/share, Select Medical’s sale for $16.50/share, and TopBuild’s proposed acquisition by QXO. The firm also flagged QXO’s merger with TopBuild and said it may seek higher consideration or additional disclosures.

$QXOHighAI 9/10

Are KORE, SEM, BLD, QXO Obtaining Fair Deals for their Shareholders?

Halper Sadeh LLC said it is investigating potential securities-law violations and fiduciary-duty breaches involving KORE Group Holdings’ sale to Searchlight Capital Partners and Abry Partners for $9.25/share, Select Medical’s sale to a consortium led by its executives/directors for $16.50/share, and TopBuild’s proposed deal with QXO. TopBuild holders would choose $505 cash or 20.2 QXO shares per share.